Jump Financial LLC decreased its stake in shares of MaxLinear, Inc. (NASDAQ:MXL - Free Report) by 73.7% during the 4th quarter, according to the company in its most recent filing with the SEC. The firm owned 37,840 shares of the semiconductor company's stock after selling 105,868 shares during the quarter. Jump Financial LLC's holdings in MaxLinear were worth $748,000 as of its most recent filing with the SEC.
Other large investors have also made changes to their positions in the company. Aster Capital Management DIFC Ltd acquired a new stake in MaxLinear during the fourth quarter worth $34,000. Pacer Advisors Inc. lifted its holdings in shares of MaxLinear by 29.0% during the 4th quarter. Pacer Advisors Inc. now owns 1,968 shares of the semiconductor company's stock worth $39,000 after acquiring an additional 443 shares during the period. Wealthfront Advisers LLC acquired a new stake in shares of MaxLinear during the 4th quarter valued at about $45,000. R Squared Ltd bought a new stake in MaxLinear in the fourth quarter valued at about $45,000. Finally, Larson Financial Group LLC raised its position in MaxLinear by 3,092.0% in the fourth quarter. Larson Financial Group LLC now owns 2,809 shares of the semiconductor company's stock worth $56,000 after purchasing an additional 2,721 shares in the last quarter. Institutional investors and hedge funds own 90.79% of the company's stock.
Wall Street Analyst Weigh In
Several equities research analysts have recently weighed in on the company. Northland Securities upped their price objective on MaxLinear from $25.00 to $27.50 and gave the company an "outperform" rating in a research note on Monday, January 6th. Needham & Company LLC reiterated a "hold" rating on shares of MaxLinear in a research report on Thursday, January 30th. Benchmark cut their price objective on MaxLinear from $28.00 to $20.00 and set a "buy" rating for the company in a report on Tuesday, April 15th. Stifel Nicolaus lowered their target price on shares of MaxLinear from $26.00 to $16.00 and set a "buy" rating on the stock in a report on Thursday, April 17th. Finally, Susquehanna cut their price target on shares of MaxLinear from $25.00 to $23.00 and set a "neutral" rating for the company in a report on Thursday, January 30th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, MaxLinear currently has a consensus rating of "Hold" and a consensus target price of $22.36.
Read Our Latest Research Report on MXL
MaxLinear Stock Performance
Shares of NASDAQ:MXL opened at $10.41 on Wednesday. The business has a fifty day moving average of $12.60 and a 200-day moving average of $15.86. The firm has a market cap of $881.04 million, a PE ratio of -3.55 and a beta of 1.82. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.28 and a current ratio of 1.77. MaxLinear, Inc. has a twelve month low of $8.35 and a twelve month high of $26.59.
MaxLinear (NASDAQ:MXL - Get Free Report) last announced its earnings results on Wednesday, January 29th. The semiconductor company reported ($0.27) earnings per share for the quarter, missing analysts' consensus estimates of ($0.13) by ($0.14). MaxLinear had a negative return on equity of 21.94% and a negative net margin of 68.01%. On average, equities research analysts predict that MaxLinear, Inc. will post -0.37 EPS for the current fiscal year.
MaxLinear Profile
(
Free Report)
MaxLinear, Inc provides communications systems-on-chip solutions worldwide. Its products integrate various portions of a high-speed communication system, including radio frequency, high-performance analog, mixed-signal, digital signal processing, security engines, data compression and networking layers, and power management.
Recommended Stories
Want to see what other hedge funds are holding MXL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MaxLinear, Inc. (NASDAQ:MXL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider MaxLinear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and MaxLinear wasn't on the list.
While MaxLinear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.